![]() | Related Articles |
CT and PET/CT findings of main pulmonary diffuse giant B-cell lymphoma: One case report and literature evaluation.
Medication (Baltimore). 2017 Nov;96(47):e8876
Authors: Bai Y, Liang W
Summary
RATIONALE: Major pulmonary diffuse giant B-cell lymphoma (PPL-DLBCL) is uncommon and its scientific manifestations lack specificity. On this report, we current one case of PPL-DLBCL with full scientific and imaging information, together with uncontrast-enhanced CT, contrast-enhanced CT, and positron emission tomography (PET)/CT. Earlier instances may also be reviewed and summarized.
PATIENT CONCERNS: A 62-year-old lady was hospitalized attributable to a swelling ache positioned in the correct aspect of her again that endured for >1 month. Native CT examination indicated a pulmonary an infection and anti-infective remedy was administered; nonetheless, her signs didn’t enhance. Within the hospital, a lung CT scan with enhancement confirmed hyperintensity of the correct higher lobe (RUL), ill-defined margins, inhomogeneous density, with air bronchograms, and mild-to-moderate enhancement. PET/CT confirmed a slight hyperintensity of mass with excessive uptake (about 14.7 standardized uptake worth [SUV]), and no excessive uptake was present in different areas.
INTERVENTIONS: A CT-guided percutaneous needle biopsy with Tru-Minimize needles was carried out.
DIAGNOSES: The ultimate analysis was PPL-DLBCL.
OUTCOMES: After four rounds of chemotherapy utilizing the rituximab-cyclophosphamide hydroxydaunorubicin oncovin prednisolone (R-CHOP) routine, the affected person’s ache was considerably relieved.
LESSONS: Lastly, the PPL-DLBCL manifestation was much like different sorts of PPL scientific manifestations and CT manifestations, however the PPL-DLBCL PET/CT confirmed an obvious, excessive metabolism. CT-guided percutaneous transthoracic needle biopsy can clearly diagnose the illness.
PMID: 29382010 [PubMed – in process]